About Enhancer

Enhancer ID: E_02_0771
Species: mouse
Position : chr2:126601468-126603468
Biosample name:
Experiment class : Low+High throughput
Enhancer type: Enhancer
Disease: Ige/mast cell-mediated anaphylaxis
Pubmed ID:  29277702
Enhancer experiment: ChIP-seq,Luciferase Reporter Assay
Enhancer experiment description: Chromatin immunoprecipitation sequencing analysis identified putative Hdc enhancers.Luciferase reporter transcription assay confirmed enhancer activities of putative enhancers in the Hdc gene.MITF bound to an enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene and directed enhancer activity.To determine whether the putative Hdc Enhancers function in Hdc gene transcription, we constructed a luciferase reporter gene in which luciferase expression is under the control of the Hdc minimal promoter (-44 to +1 relative to the TSS) and the -8.8 or +0.3 Hdc Enhancer. We found that the -8.8 Hdc Enhancer dramatically increased the activity of the Hdc minimal promoter (13.4-fold increase) , whereas the +0.3 Hdc Enhancer failed to show significant Enhancer activity.

About Target gene

Target gene : Hdc(AW108189-a,Hdc-c,Hdc-e,Hdc-s,Hdc),Hdc(AW108189-a,Hdc-c,Hdc-e,Hdc-s,Hdc),Hdc(AW108189-a,Hdc-c,Hdc-e,Hdc-s,Hdc)
Strong evidence: --
Less strong evidence: ChIP-qPCR,Luciferase Reporter Assay
Target gene experiment description: Chromatin immunoprecipitation sequencing analysis identified putative Hdc enhancers.Luciferase reporter transcription assay confirmed enhancer activities of putative enhancers in the Hdc gene.MITF bound to an enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene and directed enhancer activity.;Chromatin immunoprecipitation sequencing analysis identified putative Hdc enhancers.Luciferase reporter transcription assay confirmed enhancer activities of putative enhancers in the Hdc gene.MITF bound to an enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene and directed enhancer activity.;Chromatin immunoprecipitation sequencing analysis identified putative Hdc enhancers.Luciferase reporter transcription assay confirmed enhancer activities of putative enhancers in the Hdc gene.MITF bound to an enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene and directed enhancer activity.

About TF

TF name : Gata2(DCML,IMD21,MONOMAC,NFE1B)Mitf(CMM8,COMMAD,MI,WS2,WS2A,bHLHe32)Gata2(DCML,IMD21,MONOMAC,NFE1B)Mitf(CMM8,COMMAD,MI,WS2,WS2A,bHLHe32)Gata2(DCML,IMD21,MONOMAC,NFE1B)Mitf(CMM8,COMMAD,MI,WS2,WS2A,bHLHe32)
TF experiment: ChIP-qPCR,shRNA,Luciferase Reporter Assay
TF experiment description: Our ChIP-qPCR analysis of MITF binding in BMMCs revealed that among five predicted MITF-binding sites located within the -8.8 and +0.3 Hdc Enhancers.We found that Hdc mRNA expression was significantly diminished (70% reduction) in TBMMCs with knocked down Mitf mRNA expression.Conversely, overexpression of MITF in a non-mast cell line greatly 383 increased the activity of the -8.8 Hdc Enhancer.;Our ChIP-qPCR analysis of MITF binding in BMMCs revealed that among five predicted MITF-binding sites located within the -8.8 and +0.3 Hdc Enhancers.We found that Hdc mRNA expression was significantly diminished (70% reduction) in TBMMCs with knocked down Mitf mRNA expression.Conversely, overexpression of MITF in a non-mast cell line greatly 383 increased the activity of the -8.8 Hdc Enhancer.;Our ChIP-qPCR analysis of MITF binding in BMMCs revealed that among five predicted MITF-binding sites located within the -8.8 and +0.3 Hdc Enhancers.We found that Hdc mRNA expression was significantly diminished (70% reduction) in TBMMCs with knocked down Mitf mRNA expression.Conversely, overexpression of MITF in a non-mast cell line greatly 383 increased the activity of the -8.8 Hdc Enhancer.

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
Gata2 AP-1 transcription factor network pid 71
Gata2 Factors involved in megakaryocyte development and platelet production reactome 111
Gata2 HIF-1-alpha transcription factor network pid 67
Gata2 IL3 netpath 84
Gata2 Regulation of Androgen receptor activity pid 54
Gata2 Signaling events mediated by HDAC Class I pid 89
Gata2 Signaling events mediated by HDAC Class II pid 58
Gata2 Hs_Apoptosis_WP254_88977 wikipathways 31
Mitf IL6-mediated signaling events pid 48
Mitf KitReceptor netpath 104
Mitf RANKL netpath 84
Mitf Regulation of nuclear beta catenin signaling and target gene transcription pid 80
Mitf Regulation of retinoblastoma protein pid 67
Mitf Signaling events mediated by Stem cell factor receptor (c-Kit) pid 53
Mitf Signaling mediated by p38-alpha and p38-beta pid 35
Mitf SUMOylation of transcription factors reactome 14
Mitf Melanogenesis kegg 100
Mitf Pathways in cancer kegg 321
Mitf Melanoma kegg 69
Mitf Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Mitf Hs_Kit_receptor_signaling_pathway_WP304_78799 wikipathways 46
Mitf Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26
Gata2 AP-1 transcription factor network pid 71
Gata2 Factors involved in megakaryocyte development and platelet production reactome 111
Gata2 HIF-1-alpha transcription factor network pid 67
Gata2 IL3 netpath 84
Gata2 Regulation of Androgen receptor activity pid 54
Gata2 Signaling events mediated by HDAC Class I pid 89
Gata2 Signaling events mediated by HDAC Class II pid 58
Gata2 Hs_Apoptosis_WP254_88977 wikipathways 31
Mitf IL6-mediated signaling events pid 48
Mitf KitReceptor netpath 104
Mitf RANKL netpath 84
Mitf Regulation of nuclear beta catenin signaling and target gene transcription pid 80
Mitf Regulation of retinoblastoma protein pid 67
Mitf Signaling events mediated by Stem cell factor receptor (c-Kit) pid 53
Mitf Signaling mediated by p38-alpha and p38-beta pid 35
Mitf SUMOylation of transcription factors reactome 14
Mitf Melanogenesis kegg 100
Mitf Pathways in cancer kegg 321
Mitf Melanoma kegg 69
Mitf Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Mitf Hs_Kit_receptor_signaling_pathway_WP304_78799 wikipathways 46
Mitf Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26
Gata2 AP-1 transcription factor network pid 71
Gata2 Factors involved in megakaryocyte development and platelet production reactome 111
Gata2 HIF-1-alpha transcription factor network pid 67
Gata2 IL3 netpath 84
Gata2 Regulation of Androgen receptor activity pid 54
Gata2 Signaling events mediated by HDAC Class I pid 89
Gata2 Signaling events mediated by HDAC Class II pid 58
Gata2 Hs_Apoptosis_WP254_88977 wikipathways 31
Mitf IL6-mediated signaling events pid 48
Mitf KitReceptor netpath 104
Mitf RANKL netpath 84
Mitf Regulation of nuclear beta catenin signaling and target gene transcription pid 80
Mitf Regulation of retinoblastoma protein pid 67
Mitf Signaling events mediated by Stem cell factor receptor (c-Kit) pid 53
Mitf Signaling mediated by p38-alpha and p38-beta pid 35
Mitf SUMOylation of transcription factors reactome 14
Mitf Melanogenesis kegg 100
Mitf Pathways in cancer kegg 321
Mitf Melanoma kegg 69
Mitf Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Mitf Hs_Kit_receptor_signaling_pathway_WP304_78799 wikipathways 46
Mitf Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs